Rich May congratulates its client, Hamilton Thorne, Ltd., on its recent report that it has established a US$3 million line of credit with its commercial bank to support future acquisitions.
“This new $3 million line of credit facility, on top of the over $12 million of cash on our balance sheet, allows us to pursue our existing acquisition program with greater speed and flexibility,” stated Michael Bruns, Chief Financial Officer.
A Rich May team led by Jeffrey Loeb assisted Hamilton Thorne with the negotiation and completion of the transaction.
For information on the acquisition, click here.
About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)
Hamilton Thorne designs, manufactures and distributes precision laser devices and advanced imaging systems that reduce cost, increase productivity, improve results and enable breakthroughs in assisted reproductive technologies (ART) and developmental biology research markets. Hamilton Thorne’s laser products attach to standard inverted microscopes and operate as robotic micro-surgeons, enabling a wide array of scientific applications and IVF procedures. Its imaging systems improve outcomes in human IVF clinics and animal breeding facilities and provide high-end toxicology analyses. Hamilton Thorne’s growing worldwide customer base consists of pharmaceutical companies, biotechnology companies, fertility clinics, university research centers, animal breeding companies, and other commercial and academic research establishments, including Harvard, MIT, Yale, McGill, Oxford, Cambridge, the Smithsonian Institution, Charles River Labs, Covance, ABS Global, Sexing Technologies, Merck, Novartis, Pfizer, and Dow Chemical.